Advertisement Bioheart names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bioheart names new CEO

Bioheart has appointed Howard Leonhardt, co-founder, chairman of the board and chief technology officer of the company as its new CEO.

This follows the resignation of William Pinon as the company’s president and CEO and as a member of the board of directors as of the same date.

Mr Pinon has agreed to remain with the company through July 25, 2008 to assist in the executive transition process.

Mr Leonhardt said: “I look forward to a greater level of involvement as we continue to pursue regulatory approval and commercialization of this therapy to treat congestive heart failure patients, as well as, drive the development of future generation products. We look to the future with great anticipation.”